|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - REGENXBIO Inc. (RGNX)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-06-19 Sale |
2019-06-21 4:11 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $52.54 | $788,088 | 261,000 (Direct) |
View |
| 2019-06-18 Sale |
2019-06-20 4:20 pm |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
5,000 | $52.99 | $264,965 | 44,931 (Direct) |
View |
| 2019-05-28 Sale |
2019-05-30 4:56 pm |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
18,000 | $50 | $900,000 | 57,500 (Direct) |
View |
| 2019-05-20 Sale |
2019-05-22 4:18 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $42.99 | $644,866 | 261,000 (Direct) |
View |
| 2019-04-22 Sale |
2019-04-24 4:20 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $50.44 | $756,566 | 261,000 (Direct) |
View |
| 2019-04-18 Sale |
2019-04-22 4:17 pm |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
5,000 | $53.23 | $266,161 | 49,931 (Direct) |
View |
| 2019-04-15 Sale |
2019-04-17 4:19 pm |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
2,000 | $52.66 | $105,320 | 71,500 (Direct) |
View |
| 2019-03-21 Sale |
2019-03-25 12:32 pm |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
10,000 | $60.75 | $607,539 | 230,915 (Direct) |
View |
| 2019-03-19 Sale |
2019-03-21 4:17 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $58.53 | $877,989 | 261,000 (Direct) |
View |
| 2019-03-05 Sale |
2019-03-07 4:23 pm |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
3,068 | $60.01 | $184,111 | 239,215 (Direct) |
View |
| 2019-02-25 Sale |
2019-02-27 5:35 pm |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
5,300 | $54.05 | $286,465 | 44,800 (Direct) |
View |
| 2019-02-14 Sale |
2019-02-19 4:19 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $47.29 | $709,284 | 261,000 (Direct) |
View |
| 2019-02-05 Sale |
2019-02-07 4:18 pm |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
43,832 | $50.08 | $2,195,107 | 83,332 (Direct) |
View |
| 2019-01-15 Sale |
2019-01-17 4:18 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $43.85 | $657,698 | 204,140 (Direct) |
View |
| 2018-12-18 Sale |
2018-12-20 4:27 pm |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
5,000 | $47.54 | $237,698 | 53,472 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 4:32 pm |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
7,500 | $46.35 | $347,650 | 125,683 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 4:20 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $46.73 | $700,927 | 223,396 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-06 4:22 pm |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
20,414 | $60.13 | $1,227,412 | 40,830 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-06 4:19 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
20,000 | $60.4 | $1,208,087 | 232,300 (Direct) |
View |
| 2018-11-29 Sale |
2018-12-03 4:19 pm |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
12,784 | $65 | $830,960 | 53,000 (Direct) |
View |
| 2018-11-26 Sale |
2018-11-28 4:20 pm |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
20,507 | $65.03 | $1,333,519 | 65,784 (Direct) |
View |
| 2018-11-26 Sale |
2018-11-28 4:18 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
20,000 | $64.17 | $1,283,355 | 259,620 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-06-19 Exercise |
2019-06-21 4:11 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $0.85 | 261,000 (Direct) |
View |
| 2019-06-19 Exercise |
2019-06-21 4:11 pm |
N/A 2024-09-23 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $0.85 | 261,000 (Direct) |
View |
| 2019-06-18 Exercise |
2019-06-20 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
5,000 | $12.1 | 44,931 (Direct) |
View |
| 2019-06-18 Exercise |
2019-06-20 4:20 pm |
N/A 2026-08-17 |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
5,000 | $12.1 | 44,931 (Direct) |
View |
| 2019-05-31 Option Award |
2019-06-04 4:25 pm |
N/A 2029-05-31 |
REGENXBIO Inc. | RGNX | Fox Allan M. Director |
10,000 | $43.02 | 10,000 (Direct) |
View |
| 2019-05-31 Option Award |
2019-06-04 4:24 pm |
N/A 2029-05-31 |
REGENXBIO Inc. | RGNX | Tasse Daniel Director |
10,000 | $43.02 | 10,000 (Direct) |
View |
| 2019-05-31 Option Award |
2019-06-04 4:23 pm |
N/A 2029-05-31 |
REGENXBIO Inc. | RGNX | STUMP DAVID C Director |
10,000 | $43.02 | 10,000 (Direct) |
View |
| 2019-05-31 Option Award |
2019-06-04 4:22 pm |
N/A 2029-05-31 |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
10,000 | $43.02 | 10,000 (Direct) |
View |
| 2019-05-31 Option Award |
2019-06-04 4:21 pm |
N/A 2029-05-31 |
REGENXBIO Inc. | RGNX | HAYDEN DONALD J JR Director |
10,000 | $43.02 | 10,000 (Direct) |
View |
| 2019-05-31 Option Award |
2019-06-04 4:19 pm |
N/A 2029-05-31 |
REGENXBIO Inc. | RGNX | Glucksmann Alexandra Director |
10,000 | $43.02 | 10,000 (Direct) |
View |
| 2019-05-31 Option Award |
2019-06-04 4:17 pm |
N/A 2029-05-31 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
10,000 | $43.02 | 10,000 (Direct) |
View |
| 2019-05-31 Option Award |
2019-06-04 4:16 pm |
N/A 2029-05-31 |
REGENXBIO Inc. | RGNX | Abdun-Nabi Daniel Director |
10,000 | $43.02 | 10,000 (Direct) |
View |
| 2019-05-28 Exercise |
2019-05-30 4:56 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
18,000 | $22 | 57,500 (Direct) |
View |
| 2019-05-28 Exercise |
2019-05-30 4:56 pm |
N/A 2025-08-30 |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
18,000 | $22 | 57,500 (Direct) |
View |
| 2019-05-20 Exercise |
2019-05-22 4:18 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $0.85 | 261,000 (Direct) |
View |
| 2019-05-20 Exercise |
2019-05-22 4:18 pm |
N/A 2024-09-23 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $0.85 | 261,000 (Direct) |
View |
| 2019-04-22 Exercise |
2019-04-24 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $0.85 | 261,000 (Direct) |
View |
| 2019-04-22 Exercise |
2019-04-24 4:20 pm |
N/A 2024-09-23 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $0.85 | 261,000 (Direct) |
View |
| 2019-04-18 Exercise |
2019-04-22 4:17 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
3,541 | $12.1 | 49,931 (Direct) |
View |
| 2019-04-18 Exercise |
2019-04-22 4:17 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
1,459 | $19.5 | 49,931 (Direct) |
View |
| 2019-04-18 Exercise |
2019-04-22 4:17 pm |
N/A 2026-08-17 |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
3,541 | $12.1 | 49,931 (Direct) |
View |
| 2019-04-18 Exercise |
2019-04-22 4:17 pm |
N/A 2027-01-03 |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
1,459 | $19.5 | 49,931 (Direct) |
View |
| 2019-04-17 Option Award |
2019-04-19 4:14 pm |
N/A 2029-04-17 |
REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer |
95,000 | $54.72 | 95,000 (Direct) |
View |
| 2019-04-15 Exercise |
2019-04-17 4:19 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
2,000 | $20.35 | 71,500 (Direct) |
View |
| 2019-04-15 Exercise |
2019-04-17 4:19 pm |
N/A 2027-03-26 |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
2,000 | $20.35 | 71,500 (Direct) |
View |
| 2019-03-19 Exercise |
2019-03-21 4:17 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $0.85 | 261,000 (Direct) |
View |
| 2019-03-19 Exercise |
2019-03-21 4:17 pm |
N/A 2024-09-23 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $0.85 | 261,000 (Direct) |
View |
| 2019-03-12 Exercise |
2019-03-14 4:17 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
5,000 | $20.35 | 73,500 (Direct) |
View |
| 2019-03-12 Exercise |
2019-03-14 4:17 pm |
N/A 2027-03-26 |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
5,000 | $20.35 | 73,500 (Direct) |
View |
| 2019-02-25 Exercise |
2019-02-27 5:35 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
5,300 | $35.8 | 44,800 (Direct) |
View |
| 2019-02-25 Exercise |
2019-02-27 5:35 pm |
N/A 2028-01-03 |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
5,300 | $35.8 | 44,800 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-19 4:19 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $0.85 | 261,000 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-19 4:19 pm |
N/A 2024-09-23 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $0.85 | 261,000 (Direct) |
View |
| 2019-02-07 Exercise |
2019-02-11 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
120,000 | $0.85 | 242,283 (Direct) |
View |
| 2019-02-07 Exercise |
2019-02-11 4:20 pm |
N/A 2024-09-23 |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
120,000 | $0.85 | 242,283 (Direct) |
View |
| 2019-02-05 Exercise |
2019-02-07 4:18 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
8,450 | $35.8 | 83,332 (Direct) |
View |
| 2019-02-05 Exercise |
2019-02-07 4:18 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
32,882 | $22 | 83,332 (Direct) |
View |
| 2019-02-05 Exercise |
2019-02-07 4:18 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
1,875 | $19.5 | 83,332 (Direct) |
View |
| 2019-02-05 Exercise |
2019-02-07 4:18 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
625 | $13.09 | 83,332 (Direct) |
View |
| 2019-02-05 Exercise |
2019-02-07 4:18 pm |
N/A 2028-01-03 |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
8,450 | $35.8 | 83,332 (Direct) |
View |
| 2019-02-05 Exercise |
2019-02-07 4:18 pm |
N/A 2025-08-30 |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
32,882 | $22 | 83,332 (Direct) |
View |
| 2019-02-05 Exercise |
2019-02-07 4:18 pm |
N/A 2027-01-03 |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
1,875 | $19.5 | 83,332 (Direct) |
View |
| 2019-02-05 Exercise |
2019-02-07 4:18 pm |
N/A 2026-01-27 |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
625 | $13.09 | 83,332 (Direct) |
View |
| 2019-02-01 Exercise |
2019-02-05 4:21 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
45,000 | $0.85 | 246,000 (Direct) |
View |
| 2019-02-01 Exercise |
2019-02-05 4:21 pm |
N/A 2024-09-23 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
45,000 | $0.85 | 246,000 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-07 4:27 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
337 | $35.66 | 45,000 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-07 4:27 pm |
N/A 2029-01-03 |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
45,000 | $40.82 | 45,000 (Direct) |
View |
| 2019-01-03 Option Award |
2019-01-07 4:25 pm |
N/A 2029-01-03 |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
46,000 | $40.82 | 46,000 (Direct) |
View |
| 2019-01-03 Option Award |
2019-01-07 4:24 pm |
N/A 2029-01-03 |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
48,000 | $40.82 | 48,000 (Direct) |
View |
| 2019-01-03 Option Award |
2019-01-07 4:23 pm |
N/A 2029-01-03 |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
57,000 | $40.82 | 57,000 (Direct) |
View |
| 2019-01-03 Option Award |
2019-01-07 4:20 pm |
N/A 2029-01-03 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
190,000 | $40.82 | 190,000 (Direct) |
View |
| 2018-12-18 Exercise |
2018-12-20 4:27 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
5,000 | $12.1 | 53,472 (Direct) |
View |
| 2018-12-18 Exercise |
2018-12-20 4:27 pm |
N/A 2026-08-17 |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
5,000 | $12.1 | 53,472 (Direct) |
View |
| 2018-12-03 Exercise |
2018-12-06 4:22 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
20,414 | $0.85 | 40,830 (Direct) |
View |
| 2018-12-03 Exercise |
2018-12-06 4:22 pm |
N/A 2024-11-03 |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
20,414 | $0.85 | 40,830 (Direct) |
View |
| 2018-11-30 Exercise |
2018-12-04 4:19 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
1,500 | $20.35 | 78,500 (Direct) |
View |
| 2018-11-30 Exercise |
2018-12-04 4:19 pm |
N/A 2027-03-26 |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
1,500 | $20.35 | 78,500 (Direct) |
View |
| 2018-11-29 Exercise |
2018-12-03 4:19 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
12,784 | $3.76 | 53,000 (Direct) |
View |
| 2018-11-29 Exercise |
2018-12-03 4:19 pm |
N/A 2025-05-18 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
12,784 | $3.76 | 53,000 (Direct) |
View |
| 2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
1,721 | $49.45 | 65,784 (Direct) |
View |
| 2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
883 | $49.45 | 65,784 (Direct) |
View |
| 2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
4,687 | $22 | 65,784 (Direct) |
View |
| 2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
6,250 | $18.85 | 65,784 (Direct) |
View |
| 2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
6,250 | $12.74 | 65,784 (Direct) |
View |
| 2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
716 | $3.76 | 65,784 (Direct) |
View |
| 2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A 2028-05-25 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
1,721 | $49.45 | 65,784 (Direct) |
View |
| 2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A 2028-05-25 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
883 | $49.45 | 65,784 (Direct) |
View |
| 2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A 2025-09-16 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
4,687 | $22 | 65,784 (Direct) |
View |
| 2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A 2027-05-24 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
6,250 | $18.85 | 65,784 (Direct) |
View |
| 2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A 2026-06-01 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
6,250 | $12.74 | 65,784 (Direct) |
View |
| 2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A 2025-05-18 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
716 | $3.76 | 65,784 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Mon, 15 Jul 2019 23:16:37 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |